Quantitative


Gaming Webinar

Innovation 2020: L&G Qual Quant Case Studies [Webinar recording]

On demand webinar sharing concrete examples of deep dive qualitative case studies illustrating how lotteries across North America are successfully leveraging digital approaches to innovate in the sector.
Consumers Event

[EVENT] IIeX 2019 NA

On April 23, Ipsos is delighted that our very own Brittany Calvert is among the industry’s next generation of leaders.

[EVENT] What's New in Market Research 2018

May 24 - Don’t miss out on the latest developments and innovations in market research! Join us for our 2nd What’s New in Market Research event!
Qualitative Survey

To Qual or to Quant? That is the Question

When winter wind gives way to summer sun, Chicago’s sidewalk cafés and rooftop bars reopen to much celebration. Family, friends, and coworkers meet up for a drink, a snack, or simply to people-watch.

[EVENT] NASPL Professional Development Seminar

On July 24, join Ipsos lottery & gaming experts for two insightful presentations at this year’s NASPL professional development conference.
Analytics Publication

Making the Most of Text Analytics

Why the automated brain of text analytics still needs a human heart. While many tools or suppliers use generic frameworks or templates for text analytics, Ipsos believes that a customised approach is the best way to deliver insight.
Data Analytics Publication

Getting Started In Text Analytics - The Question To Ask

As the number of text analytics tools have proliferated, the market has moved past early concerns about accuracy and now sits in a place where picking the right tool is more about ensuring the outputs will fit your needs. We outline below six key questions which may help.
Quantitative Survey

Ipsos Most Awarded Research Agency at MRIA Event

Ipsos in Canada wins 4 in 8 awards at Marketing Research and Intelligence Association (MRIA) conference. Ipsos and its clients were recently honoured at the MRIA Awards during the 2016 National Conference in Montreal.
Healthcare Publication

Who Will Win the Race to Treat NASH?

Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.